Identificador persistente para citar o vincular este elemento:
https://accedacris.ulpgc.es/handle/10553/140973
Campo DC | Valor | idioma |
---|---|---|
dc.contributor.author | González Domínguez, María Del Carmen | en_US |
dc.contributor.author | Fornell-Perez, Roberto | en_US |
dc.contributor.author | Santana Suarez, Ernesto | en_US |
dc.contributor.author | Riol Sancho, Diego | en_US |
dc.contributor.author | Dominguez, Elisabet Gonzalez | en_US |
dc.contributor.author | Loro Ferrer, Juan Francisco | en_US |
dc.date.accessioned | 2025-06-23T09:04:55Z | - |
dc.date.available | 2025-06-23T09:04:55Z | - |
dc.date.issued | 2025 | en_US |
dc.identifier.issn | 1070-3004 | en_US |
dc.identifier.other | WoS | - |
dc.identifier.uri | https://accedacris.ulpgc.es/handle/10553/140973 | - |
dc.description.abstract | Objectives: To evaluate the predictive value of two radiological markers, the spot sign and leakage sign, for spontaneous intracranial hematoma expansion and their association with clinical outcomes, including neurological deterioration and in-hospital mortality. Materials & methods: This prospective single-center study included 94 adult patients with spontaneous intraparenchymal hemorrhagic stroke, confirmed by non-enhanced CT (NECT) and contrast-enhanced CT (CECT) in the arterial phase. Hematoma volumes and spot/leakage signs were assessed using standardized imaging protocols and analyzed by two blinded neuroradiologists. Clinical and radiological data were evaluated using multivariate analyses, with survival outcomes compared via Kaplan-Meier curves. Statistical significance was set at p <= 0.05. Results: Among 94 patients, hematoma expansion occurred in 42%, neurological deterioration in 15.5%, and mortality in 39.4%. The leakage sign was the strongest independent predictor of hematoma expansion (OR: 9.27, 95% CI: 2.95-29.20), neurological deterioration (OR: 26.67, 95% CI: 1.62-47.39), and mortality (OR: 7.56, 95% CI: 2.97-19.25). The spot and leakage signs demonstrated high specificity for predicting outcomes, with the leakage sign showing greater sensitivity for hematoma expansion. Patients with a positive leakage sign had significantly lower median survival (6 days) compared to those with a positive spot sign alone (54 days) or no signs (110 days, p < 0.001). Conclusion: The leakage sign demonstrated greater sensitivity and comparable specificity to the spot sign for predicting hematoma expansion. Both signs were associated with neurological deterioration and in-hospital mortality, with the leakage sign showing a stronger predictive value. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Emergency Radiology | en_US |
dc.source | Emergency Radiology [ISSN 1070-3004], (2025) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 320111 Radiología | en_US |
dc.subject | 320507 Neurología | en_US |
dc.subject.other | Blood-Pressure Reduction | en_US |
dc.subject.other | Intracerebral Hemorrhage | en_US |
dc.subject.other | Computed-Tomography | en_US |
dc.subject.other | Growth | en_US |
dc.subject.other | Acute Stroke | en_US |
dc.subject.other | Intracranial Hemorrhages | en_US |
dc.subject.other | Computed Tomography | en_US |
dc.subject.other | Inhospital Mortality | en_US |
dc.subject.other | Neurological Deterioration | en_US |
dc.subject.other | Predictive Value Of Tests | en_US |
dc.title | Comparative assessment of the spot sign and leakage sign as predictive factors for spontaneous intracranial hematoma expansion | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1007/s10140-025-02352-3 | en_US |
dc.identifier.isi | 001507251300001 | - |
dc.identifier.eissn | 1438-1435 | - |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.contributor.daisngid | No ID | - |
dc.description.numberofpages | 10 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Domínguez, MDG | - |
dc.contributor.wosstandard | WOS:Fornell-Pérez, R | - |
dc.contributor.wosstandard | WOS:Suárez, ES | - |
dc.contributor.wosstandard | WOS:Sancho, DR | - |
dc.contributor.wosstandard | WOS:Domínguez, EG | - |
dc.contributor.wosstandard | WOS:Loro-Ferrer, JF | - |
dc.date.coverdate | 2025 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 0,494 | |
dc.description.sjrq | Q2 | |
dc.description.esci | ESCI | |
dc.description.miaricds | 10,0 | |
item.fulltext | Con texto completo | - |
item.grantfulltext | open | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.dept | GIR IUIBS: Bioquímica | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.orcid | 0000-0002-0517-8209 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | González Domínguez, María Del Carmen | - |
crisitem.author.fullName | Loro Ferrer, Juan Francisco | - |
Colección: | Artículos |
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.